371 related articles for article (PubMed ID: 28448738)
1. Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system.
Anton T; Bultmann S
Nucleus; 2017 May; 8(3):279-286. PubMed ID: 28448738
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
[TBL] [Abstract][Full Text] [Related]
3. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
4. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
6. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
Song MK; Kim YS
Methods Mol Biol; 2024; 2761():81-91. PubMed ID: 38427231
[TBL] [Abstract][Full Text] [Related]
7. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
[TBL] [Abstract][Full Text] [Related]
8. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
[TBL] [Abstract][Full Text] [Related]
9. Precise epigenomic editing with a SunTag-based modular epigenetic toolkit.
Guhathakurta S; Adams L; Jeong I; Sivakumar A; Cha M; Bernardo Fiadeiro M; Hu HN; Kim YS
Epigenetics; 2022 Dec; 17(13):2075-2081. PubMed ID: 35920441
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Editing by CRISPR-guided Excision of 5-Methylcytosine.
Devesa-Guerra I; Morales-Ruiz T; Pérez-Roldán J; Parrilla-Doblas JT; Dorado-León M; García-Ortiz MV; Ariza RR; Roldán-Arjona T
J Mol Biol; 2020 Mar; 432(7):2204-2216. PubMed ID: 32087201
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-mediated promoter de/methylation technologies for gene regulation.
Sung CK; Yim H
Arch Pharm Res; 2020 Jul; 43(7):705-713. PubMed ID: 32725389
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system.
Kang JG; Park JS; Ko JH; Kim YS
Sci Rep; 2019 Aug; 9(1):11960. PubMed ID: 31427598
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9.
Sapozhnikov DM; Szyf M
Nat Commun; 2021 Sep; 12(1):5711. PubMed ID: 34588447
[TBL] [Abstract][Full Text] [Related]
15. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
16. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
[TBL] [Abstract][Full Text] [Related]
17. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems.
Papikian A; Liu W; Gallego-Bartolomé J; Jacobsen SE
Nat Commun; 2019 Feb; 10(1):729. PubMed ID: 30760722
[TBL] [Abstract][Full Text] [Related]
18. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
Nguyen TV; Lister R
Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
20. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]